-
1
Subacute parkinsonism induced by immune checkpoint inhibitors
Published 2024-12-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
2
A case report of immune checkpoint inhibitor-associated pituitary inflammation with hypotension as the initial symptom
Published 2025-01-01Subjects: “…Immune checkpoint inhibitor…”
Get full text
Article -
3
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Published 2024-12-01Subjects: Get full text
Article -
4
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Published 2024-12-01Subjects: Get full text
Article -
5
Proteinuria following administration of immune check point inhibitor: a case-control observational study
Published 2024-11-01Subjects: Get full text
Article -
6
Case report: Diagnosis of impaired consciousness in a cancer patient using immune checkpoint inhibitors
Published 2025-01-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
7
Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis
Published 2024-12-01Subjects: Get full text
Article -
8
Immunotherapy against glioblastoma using backpack‐activated neutrophils
Published 2025-01-01Subjects: Get full text
Article -
9
Hyperthermia combined with immune checkpoint inhibitor therapy: Synergistic sensitization and clinical outcomes
Published 2023-02-01Subjects: Get full text
Article -
10
Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
Published 2023-04-01Subjects: Get full text
Article -
11
David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma
Published 2024-01-01Subjects: Get full text
Article -
12
Global research trends on biomarkers for cancer immunotherapy: Visualization and bibliometric analysis
Published 2025-12-01Subjects: Get full text
Article -
13
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Published 2025-01-01Subjects: Get full text
Article -
14
Pembrolizumab-induced cytokine release syndrome with severe encephalopathy in the setting of clear cell vaginal carcinoma: A case report
Published 2024-12-01Subjects: Get full text
Article -
15
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
Published 2024-11-01Subjects: Get full text
Article -
16
Salvage surgery after combination immunotherapy for initially unresectable or metastastic hepatocellular carcinoma: A retrospective clinical study
Published 2023-12-01Subjects: Get full text
Article -
17
Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment
Published 2024-12-01Subjects: Get full text
Article -
18
Current Status and Prospects of Fertility Preservation Strategies for Patients with Tumors
Published 2024-12-01Subjects: Get full text
Article -
19
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
Published 2025-02-01Subjects: Get full text
Article -
20
From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment
Published 2025-12-01Subjects: Get full text
Article